Boehringer Ingelheim announces the start of the THULITE Phase II clinical study. It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral treatment to improve vision ...

In a significant step towards tackling one of the UK’s most underdiagnosed conditions, North East and North Cumbria Integrated Care Board (ICB) has adopted the Healthinote digital health platform, ...

Germany’s ARD broadcaster has hailed Greece’s transformation from a “problem child” of the eurozone to a “model student,” ...

DelveInsight's“ Obesity Pipeline Insigh t 2025 ” report provides comprehensive insights about 80+ companies and 100+ pipeline ...

Pioneer in RNA research who gave children with SMA a future Sabine Löwer Communications Boehringer Ingelheim St ...

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

North East and North Cumbria NHS has begun a year-long rollout of the Healthinote digital health platform to support patients ...

Healthinote is a smartphone-based toolkit designed to boost patient engagement by providing personalised, trustworthy, and ...

Managing type 1 diabetes has a substantial impact on quality of life and psychological health. Indeed, insulin overdosing can ...

The Centre considers fixing retail prices for empagliflozin combinations as generic versions flood the market and lead to ...

In an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad ...

Manila, Philippines — Hotel Okura Manila, in partnership with Newport World Resorts, hosted an intimate gathering of distinguished guests for Kaien, the official opening of Philippines–Japan ...